دورية أكاديمية

Management and prevention of corneal graft rejection.

التفاصيل البيبلوغرافية
العنوان: Management and prevention of corneal graft rejection.
المؤلفون: Mandal S; Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India., Maharana PK; Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India., Kaweri L; Consultant, Narayana Nethralaya, Bengaluru, Karnataka, India., Asif MI; Consultant, Eye7 Chaudhary Eye Centre, New Delhi, India., Nagpal R; Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India., Sharma N; Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
المصدر: Indian journal of ophthalmology [Indian J Ophthalmol] 2023 Sep; Vol. 71 (9), pp. 3149-3159.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print Cited Medium: Internet ISSN: 1998-3689 (Electronic) Linking ISSN: 03014738 NLM ISO Abbreviation: Indian J Ophthalmol Subsets: MEDLINE
أسماء مطبوعة: Publication: Mumbai : Medknow Publications
Original Publication: Bombay : All-India Ophthalmological Society
مواضيع طبية MeSH: Corneal Diseases*/surgery , Corneal Transplantation*/adverse effects, Humans ; Graft Rejection/prevention & control ; Cornea ; Immunosuppression Therapy
مستخلص: The management of an episode of corneal graft rejection (CGR) is primarily by corticosteroids. Immunomodulators are useful for long-term immunosuppression and in dealing with cases of high-risk (HR) corneal grafts. The classical signs of CGR following penetrating keratoplasty (PKP) include rejection line, anterior chamber (AC) reaction, and graft edema. However, these signs may be absent or subtle in cases of endothelial keratoplasty (EK). Prevention of an episode of graft rejection is of utmost importance as it can reduce the need for donor cornea significantly. In our previous article (IJO_2866_22), we had discussed about the immunopathogenesis of CGR. In this review article, we aim to discuss the various clinical aspects and management of CGR.
Competing Interests: None
References: Am J Ophthalmol. 2005 Feb;139(2):311-9. (PMID: 15733993)
Indian J Ophthalmol. 2013 Aug;61(8):465-8. (PMID: 23925339)
Curr Ophthalmol Rep. 2017 Mar;5(1):38-48. (PMID: 28959505)
Eur J Pharm Sci. 2019 May 15;133:104-114. (PMID: 30928512)
Am J Ophthalmol. 2007 Aug;144(2):318-9. (PMID: 17659972)
J Exp Med. 2002 Jan 21;195(2):259-68. (PMID: 11805152)
Br J Ophthalmol. 2004 Jun;88(6):840. (PMID: 15148229)
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1043-52. (PMID: 17325145)
Immunol Cell Biol. 2003 Apr;81(2):93-105. (PMID: 12631232)
Transplantation. 2015 Apr;99(4):678-86. (PMID: 25606789)
Cornea. 2008 Dec;27(10):1195-9. (PMID: 19034142)
Cornea. 2016 Mar;35(3):299-304. (PMID: 26785303)
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6277-85. (PMID: 20435600)
Jpn J Ophthalmol. 2001 Jul-Aug;45(4):378-82. (PMID: 11485770)
Br J Ophthalmol. 2009 Mar;93(3):391-5. (PMID: 19019938)
Eye (Lond). 2009 Mar;23(3):635-9. (PMID: 18292787)
Med J Aust. 2013 Aug 19;199(4):275-9. (PMID: 23984786)
Acta Ophthalmol Scand. 2001 Jun;79(3):251-5. (PMID: 11401633)
Am J Ophthalmol. 2011 Jun;151(6):1024-1029.e1. (PMID: 21489399)
Am J Ophthalmol. 2012 May;153(5):949-957.e1. (PMID: 22265142)
Br J Ophthalmol. 2010 Nov;94(11):1464-7. (PMID: 20576763)
Am J Ophthalmol. 2007 Jan;143(1):117-124. (PMID: 17188045)
Prog Retin Eye Res. 2015 May;46:84-110. (PMID: 25601193)
Transplantation. 2008 Dec 27;86(12):1720-4. (PMID: 19104411)
Am J Transplant. 2019 Sep;19(9):2446-2456. (PMID: 30821887)
Cornea. 2006 Oct;25(9):1005-11. (PMID: 17133044)
Cornea. 1984;3(1):17-20. (PMID: 6399229)
Hum Gene Ther. 2018 Jun;29(6):687-698. (PMID: 29361840)
Br J Ophthalmol. 2014 Sep;98(9):1287-90. (PMID: 24782468)
Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10):1375-82. (PMID: 19415316)
Ophthalmic Res. 2013;50(3):135-40. (PMID: 23941996)
Cornea. 2016 Sep;35(9):1179-81. (PMID: 27227399)
JAMA Ophthalmol. 2015 Mar;133(3):246-54. (PMID: 25322173)
Transpl Int. 2005 Jun;18(6):703-8. (PMID: 15910297)
Arch Ophthalmol. 1992 Oct;110(10):1392-403. (PMID: 1417537)
Int J Ophthalmol. 2017 Jun 18;10(6):834-839. (PMID: 28730071)
Cornea. 2012 Sep;31(9):969-73. (PMID: 22677636)
Br J Ophthalmol. 1992 Oct;76(10):577. (PMID: 1358192)
Invest Ophthalmol Vis Sci. 1991 Sep;32(10):2723-8. (PMID: 1680112)
Indian J Ophthalmol. 2013 Aug;61(8):407-9. (PMID: 23925324)
Cornea. 2010 Feb;29(2):177-82. (PMID: 20023579)
J Immunol. 2005 Aug 15;175(4):2219-26. (PMID: 16081789)
Ophthalmology. 2009 Dec;116(12):2369-72. (PMID: 19815284)
Transpl Immunol. 2002 Aug;10(2-3):125-32. (PMID: 12216942)
Clin Exp Ophthalmol. 2005 Dec;33(6):623-7. (PMID: 16402956)
Ophthalmology. 2011 Mar;118(3):591-9. (PMID: 21376242)
Am J Ophthalmol. 2013 Mar;155(3):560-569.e2. (PMID: 23218931)
Cornea. 2011 Jun;30(6):629-33. (PMID: 21217526)
Arch Ophthalmol. 1981 Apr;99(4):599-604. (PMID: 7013739)
Ophthalmology. 2012 Mar;119(3):536-40. (PMID: 22218143)
Br J Ophthalmol. 2007 Jan;91(1):51-5. (PMID: 16956911)
Br J Ophthalmol. 2009 Aug;93(8):1075-80. (PMID: 19224901)
Mediators Inflamm. 2017;2017:8670280. (PMID: 28539707)
Gene Ther. 2012 Feb;19(2):145-53. (PMID: 22052240)
J Ophthalmic Vis Res. 2017 Jan-Mar;12(1):81-92. (PMID: 28299010)
Ophthalmology. 1998 Oct;105(10):1855-65. (PMID: 9787355)
Cornea. 1999 Nov;18(6):645-51. (PMID: 10571292)
Cornea. 2007 Jan;26(1):59-64. (PMID: 17198015)
Cornea. 2011 Aug;30(8):912-6. (PMID: 21646908)
Cornea. 2008 May;27(4):488-93. (PMID: 18434855)
Am J Ophthalmol. 2010 Aug;150(2):179-84. (PMID: 20570235)
Front Immunol. 2018 Oct 08;9:2283. (PMID: 30349533)
Am J Transplant. 2012 May;12(5):1313-22. (PMID: 22300371)
Eye Contact Lens. 2014 Nov;40(6):382-9. (PMID: 25320959)
Ophthalmologe. 2007 Sep;104(9):813-6. (PMID: 17786454)
Acta Ophthalmol Scand. 1999 Oct;77(5):495-9. (PMID: 10551286)
Cornea. 2011 Aug;30(8):927-38. (PMID: 21389854)
Eye (Lond). 1995;9 ( Pt 2):247-53. (PMID: 7556726)
Am J Ophthalmol. 2014 Sep;158(3):485-95. (PMID: 24879945)
Cornea. 2013 Jul;32(7):1026-30. (PMID: 23591148)
J Immunol. 1998 May 15;160(10):5045-52. (PMID: 9590254)
Ophthalmology. 1994 Sep;101(9):1536-47. (PMID: 8090456)
Eye Contact Lens. 2013 Mar;39(2):194-8. (PMID: 23392301)
Endocrinology. 1986 Oct;119(4):1768-75. (PMID: 2428602)
Ophthalmology. 2008 Jun;115(6):e33-8. (PMID: 18439681)
Am J Ophthalmol. 2009 Mar;147(3):432-438.e3. (PMID: 19056078)
Sci Rep. 2017 Apr 20;7(1):971. (PMID: 28428556)
Transplantation. 2019 Dec;103(12):2468-2478. (PMID: 31765363)
Graefes Arch Clin Exp Ophthalmol. 2015 Feb;253(2):287-94. (PMID: 25398659)
Ophthalmology. 2015 Jun;122(6):1079-84. (PMID: 25841974)
Cornea. 2015 Jun;34(6):609-14. (PMID: 25811719)
Cornea. 1989;8(2):141-9. (PMID: 2469552)
Prog Retin Eye Res. 2019 Nov;73:100768. (PMID: 31279005)
Ophthalmology. 2001 Oct;108(10):1838-44. (PMID: 11581059)
Am J Ophthalmol. 2018 Dec;196:197-207. (PMID: 30308200)
Cornea. 2006 Apr;25(3):286-90. (PMID: 16633028)
Ophthalmology. 2011 Feb;118(2):302-9. (PMID: 20832121)
Cornea. 2008 May;27(4):446-53. (PMID: 18434849)
Cornea. 2010 Jan;29(1):60-4. (PMID: 19907304)
Ophthalmology. 2012 Apr;119(4):668-73. (PMID: 22264885)
Transplantation. 2006 Mar 15;81(5):767-72. (PMID: 16534481)
Br J Ophthalmol. 2012 Sep;96(9):1200-3. (PMID: 22826552)
Transplant Proc. 1995 Jun;27(3):2141-2. (PMID: 7792910)
Br J Ophthalmol. 2014 Apr;98(4):448-53. (PMID: 24420918)
Eye (Lond). 2009 Nov;23(11):2063-70. (PMID: 19151659)
Cornea. 2009 Dec;28(10):1124-9. (PMID: 19770712)
Transplantation. 2005 Apr 27;79(8):964-8. (PMID: 15849551)
Int Ophthalmol Clin. 2009 Winter;49(1):31-41. (PMID: 19125062)
Arch Ophthalmol. 1975 Oct;93(10):1017-9. (PMID: 1237281)
Am J Ophthalmol. 2015 Sep;160(3):416-21. (PMID: 26116262)
Cornea. 2012 Oct;31(10):1135-40. (PMID: 22367049)
Cornea. 2015 Apr;34(4):471-4. (PMID: 25742389)
Exp Eye Res. 2012 Feb;95(1):54-9. (PMID: 21777585)
Immunology. 1986 Dec;59(4):503-7. (PMID: 2948905)
Cornea. 2014 Nov;33(11):1157-63. (PMID: 25255133)
Cornea. 1992 Jul;11(4):326-8. (PMID: 1424653)
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2148-53. (PMID: 10892856)
Ophthalmology. 1994 Jan;101(1):128-33. (PMID: 8302545)
J Ophthalmic Vis Res. 2009 Jan;4(1):8-13. (PMID: 23056667)
Cornea. 2012 Oct;31(10):1141-7. (PMID: 22488114)
Ophthalmology. 1997 Mar;104(3):508-12. (PMID: 9082281)
Graefes Arch Clin Exp Ophthalmol. 2001 Feb;239(2):152-7. (PMID: 11372546)
Cornea. 2008 Aug;27(7):847-50. (PMID: 18650676)
Am J Ophthalmol. 2012 Feb;153(2):291-299.e2. (PMID: 21996306)
Transplantation. 1999 Aug 15;68(3):391-6. (PMID: 10459543)
Lasers Surg Med. 1988;8(5):450-63. (PMID: 2976443)
Cornea. 2014 Oct;33(10):1003-9. (PMID: 25119961)
Ophthalmology. 2006 Apr;113(4):556-60. (PMID: 16581417)
Cornea. 1994 Sep;13(5):440-6. (PMID: 7995069)
Exp Eye Res. 2003 May;76(5):521-42. (PMID: 12697417)
Transplant Proc. 2007 Oct;39(8):2609-11. (PMID: 17954190)
Eye (Lond). 1991;5 ( Pt 4):420-4. (PMID: 1743357)
Eye Vis (Lond). 2017 Dec 10;4:28. (PMID: 29234686)
Ocul Surf. 2012 Apr;10(2):67-83. (PMID: 22482468)
Cornea. 2011 Dec;30(12):1423-7. (PMID: 21975440)
Br J Ophthalmol. 2012 Aug;96(8):1049-50. (PMID: 22544532)
Am J Ophthalmol. 2015 Mar;159(3):505-11. (PMID: 25486540)
Klin Monbl Augenheilkd. 2008 Jan;225(1):62-5. (PMID: 18236372)
Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1167-72. (PMID: 20414783)
Am J Ophthalmol. 2011 May;151(5):760-767.e1. (PMID: 21333267)
Rom J Ophthalmol. 2019 Jan-Mar;63(1):15-22. (PMID: 31198893)
فهرسة مساهمة: Keywords: Corneal graft rejection; endothelial rejection; graft failure; immune privilege; keratoplasty
تواريخ الأحداث: Date Created: 20230821 Date Completed: 20230822 Latest Revision: 20231013
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10565940
DOI: 10.4103/IJO.IJO_228_23
PMID: 37602601
قاعدة البيانات: MEDLINE
الوصف
تدمد:1998-3689
DOI:10.4103/IJO.IJO_228_23